-BAK to the future, Kidney tubule-cell-containing device as add-on to current dialysis, to improve blood purification and quality of life of patients.

-Biohybride Kidney XB, Building next-Generation artificial kidneys by combining cells and innovative nanoporous membranes 

– ERAPERmed project ”Sparekid”. Multi-markers risk assessment of kidney sensitivity to injury to personalize pervention of acute kidney injury (2023-2026). Eutox partners Ortiz/Schanstra.

– ERAPERmed project ”SIGNAL”, Body fluid proteome SIGnatures for persoNALised intervention to pervent cardiovascular and renal complications in diabetes (2023-2026), Eutox partners Ortiz/Mischak/Schanstra

– Second funding period “Mechanisms of cardiovascular  complications  on chronic kidney disease”, SFB/TRR 219  (2022-2025); DFG-Project-ID 322900939 (Fliser/Jankowski)

– MI-TRAM (Multi-compatible Implantable Toxin Removal Augmentation Module with fluid sensing) features researchers from IMEC, RWTH Aachen University Medical Center, UMC Utrecht, and University

– Picked (2024-2028), Personalised medicine in kidney disease, MSCA-DN (EUTox partners Argiles, Mischak, Fridolin, Ortiz, Schanstra)

– “treatCKD” Novel compounds for the treatment of chronic kidney disease (01/2022-31/2024). Grant ID: ANR-21-CE18-0031 (Argiles, Schanstra)

 – DisCo-1 HORIZON-MSCA-2021 Grand agreement No. 101072828             

– PerstIgAN Funded ERA-Net PerMed programme 2019-2021                 

– UriCoV Funded ERA-Net PerMed programme 2022                        

– Kidnew: Breakthrough technologies for an implantable artificial kidney. HORIZON-EIC-2022-Pathfinder Open 2022 Programme under grand agreement No. 101099092      

–BAKtotheFUTURE: BioArtificial Kidney device consisting of living membranes for improved kidney replacement therapy. NWO-ENW-Open Technology programme, Grand No. 20775

– ERAPERmed  dialysis “Patient-Reported Outcome, Biodata and Process Data to Evaluate Dialysis Tolerability”  (October 2020 to 2022)

– EU-ITN “STRATEGY-CKD”  System omics to unravel the gut-kidney axis in chronic kidney disease (2019-2024) European Union’s Horizon 2020, Grant agreement ID: 860329 (Glorieux, Argiles, Burtey, Jankowski, Masereeuw,  Mischak, Perna, Vlahoua)

– ERA-Permed grant “Kidney Attack”, Multidimensional stratification for treatment of acute kidney injury (2019-2022). Grant agreement   ID: U1048 (Ortiz, Mischak, Schanstra)

– EU-ITN “CaReSyAn  (2018- 2021) CArdioREnal SYndrome  ANalysis European Union’s Horizon 2020, Grant agreement ID: 764474 (Argiles, Jankowski, Mischak, Schanstra, Stenvinkel, Vlahou)

– SFB TRR 219  (2018 – 2021) “Mechanisms of Cardiovascular Complications in Chronic Kidney Disease”(Fliser, Jankowski)